Document is current

Any future updates will be listed below

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Crossref DOI link: https://doi.org/10.1186/s13023-017-0693-2

Published Online: 2017-08-24

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark